Peptides DB
Research-centric peptide and protocol reference hub
Study 22 of 23Lixisenatide literatureParasitology international · Observational2026

Pyrethroid resistance intensity and mechanisms in Anopheles gambiae sensu lato (Diptera: Culicidae) from Oyo State, Nigeria.

This study shows widespread and intense pyrethroid resistance in mosquito populations in Oyo State, indicating a need for new vector control strategies beyond current methods.

Read at Parasitology internationalAdd to compare

Where it sits

this study against the rest of the lixisenatide corpus
1
Preclinical
18
Observational · this one
0
Open-label
2
Randomised
2
Reviews

Summary and findings

This study measured pyrethroid resistance levels in Anopheles gambiae sensu lato populations in Oyo State, Nigeria, using WHO diagnostic and elevated concentrations of insecticides. Resistance was observed across different local government areas, with mortality rates for permethrin ranging from 5% to 65%. The findings indicate significant spatial heterogeneity in resistance intensity and mechanisms.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Mortality for permethrin ranged from 5% (Egbeda) to 65% (Akinyele) at diagnostic dose.2026

Abstract

The authors’ words, as Parasitology international supplied them

<h4>Background</h4>Pyrethroid resistance in Anopheles gambiae sensu lato (s.l.) is increasing across Nigeria and threatens the effectiveness of long-lasting insecticidal nets (LLINs) and other pyrethroid-based interventions across Nigeria. This study quantified resistance levels, intensity, and metabolic contributions in An. gambiae s.l. populations across ecologically distinct zones of Oyo State, southwestern Nigeria, to generate evidence for locally tailored vector control strategies.<h4>Methods</h4>Between May and September 2018, immature stages of Anopheles gambiae sensu lato were collected from six Local Government Areas in Oyo State, Nigeria, with 10-15 larval habitats sampled per LGA using standard dipping procedures. Specimens were reared to adulthood under controlled insectary conditions (27 ± 2 °C; 75-84% Relative Humidity) before testing. For each insecticide in each LGA, approximately 450-550 non-blood-fed female mosquitoes were evaluated in accordance with WHO testing procedures. Susceptibility to alpha-cypermethrin (12.5 μg/bottle), deltamethrin (12.5 μg/bottle), and permethrin (21.5 μg/bottle) was determined using the CDC bottle bioassay at diagnostic concentrations (1×), with standard replicate batches per assay. Populations exhibiting resistance at 1× were further examined using elevated concentrations (2×, 5×, and 10×) to quantify resistance intensity. The involvement of metabolic detoxification was assessed through the contribution of cytochrome P450-mediated resistance mechanisms.<h4>Results</h4>A total of 9000 female mosquitoes were exposed to WHO diagnostic (1×) and elevated (2 × -10×) concentrations of alpha-cypermethrin, deltamethrin, and permethrin, complemented with piperonyl butoxide (PBO) synergist assays. At diagnostic dose, resistance was widespread, with mortality ranging from 5% (Egbeda) to 65% (Akinyele) for permethrin, 38.8-97% for alpha-cypermethrin, and 23-78% for deltamethrin, indicating significant spatial heterogeneity. Permethrin exhibited the highest resistance intensity, with incomplete mortality recovery even at 10×, while alpha-cypermethrin and deltamethrin showed full susceptibility restoration at 5× and 2×, respectively. Statistical analysis confirmed significant variation among LGAs (χ<sup>2</sup>, P < 0.001). Knockdown responses were reduced in Atiba, Afijio, and Egbeda, where several populations failed to reach 95% knockdown within 60 min. PBO pre-exposure fully restored susceptibility to alpha-cypermethrin (100%) across resistant LGAs, while deltamethrin showed partial recovery. In contrast, permethrin mortality remained incomplete (47-94%) after PBO, indicating limited metabolic involvement and likely target-site resistance.<h4>Conclusions</h4>Overall, the findings demonstrate intense, spatially heterogeneous pyrethroid resistance driven by multiple mechanisms, with important implications for malaria vector control. While PBO-based LLINs may provide partial mitigation, they are unlikely to fully address the complexity of resistance observed across the study area. Consequently, sustained control in Oyo State will require complementary and alternative strategies, including next-generation dual-active-ingredient nets and other non-pyrethroid interventions.

Elsewhere in the Lixisenatide corpus

BReal-world clinical experience with ruxolitinib cream versus systemic therapies in patients with moderate atopic dermatitis in the United States.The Journal of dermatological treatment · 2026 · n=619 · 49% reduction in affected body surface area with ruxolitinib cream.HumanAA phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer.Oncoimmunology · 2026 · n=13 · Median overall survival was 7.23 months.HumanBClinical and inflammatory determinants of successful abrocitinib dose reduction in atopic dermatitis: a real-world cohort study with implications for treatment optimization.Annals of medicine · 2026 · n=66 · Not reported in abstract.HumanCA phytotherapeutic candidate for neuropathic pain: Helicteres ovata (Lam.) extract shows antinociceptive effects and favorable acute toxicity profile.Journal of ethnopharmacology · 2026 · Not reported in abstract.AnimalCSteaming reduces Polygonum multiflorum hepatotoxicity by modulating gut microbiota-bile acid-FXR/NF-κB signaling in the gut-liver axis.Journal of ethnopharmacology · 2026 · PPM treatment reduced serum ALT by 82% compared to the PM group.AnimalBInterpretable feature-transformer framework for cross-subject MCI detection using nonlinear dynamical and graph-theoretic EEG features.Cognitive neurodynamics · 2026 · 97.04% ± 0.72 performance of the feature-based Transformer.Human